RBI imposes a total penalty of ₹3 crore on 3 PSU banks
RBI said on Friday that it has imposed a penalty of ₹1 crore each on the three banks of Union Bank of India (UBI), Bank of India and Bank of Maharashtra
Mumbai: The Reserve Bank has imposed a total penalty of ₹3 crore on three state-run banks of Union Bank of India, Bank of India and Bank of Maharashtra for delay in detection and reporting of fraud in some accounts.
The central bank in three separate releases Friday said it has imposed a penalty of ₹1 crore each on the three banks of Union Bank of India (UBI), Bank of India and Bank of Maharashtra.
The RBI on 30 August “imposed a monetary penalty of ₹10 million” on the banks for contravention of the instructions contained in Master Circular on Fraud – Classification and Reporting issued by RBI, according to the releases.
The penalty has been imposed taking into account delay on the part of the bank to detect and report fraud in an account, it said.
“This is to inform that Reserve Bank has imposed a penalty of ₹10 million on the bank for delay in detection and reporting of fraud. The penalty has been imposed in exercise of powers vested in RBI under ...Banking Regulation Act,” Union Bank of India said in a regulatory filing Friday.
The bank has taken necessary preventive measures and has implemented a comprehensive corrective action plan to strengthen internal controls and to ensure that such incidents do not recur, the bank added.
- Barista in advanced talks with Swiggy, another player for food delivery
- Insurance startup Turtlemint raises $25 million from Sequoia, Nexus, Blume Ventures
- India to bar private refiners from tapping Iran oil quota
- Snapdeal partners with RBL, Federal Bank to penetrate non-metro markets
- Cabinet approves ₹6,000 crore capital infusion in Exim Bank
Editor's Picks »
- Why Tata Motors’ Project Charge at JLR is failing to recharge its shares
- Outlook on global profit growth worst since 2008 financial crisis
- Q3 results: ICICI Securities loses its retail broking crown
- High drug approvals to keep up pricing pressure for pharma firms
- Roads sector: Toll collections set to surge, but risks loom for developers